Know what’s going around
Contagious illnesses such as flu are notoriously unpredictable, year over year and region by region. Current data sources are delayed, inaccurate or both.
Each year, health organizations, pharmaceutical companies and even local governments try to react as quickly as possible as flu unfolds, helping anywhere from 5% and 20% of the population as they come down with the virus. Vaccines, preventative products and early interventions can minimize the flu’s effect on vulnerable populations, not to mention reduce its economic impact — $42 billion over the past five years in the U.S. alone.
Kinsa Insights is the earliest and most accurate signal for infectious illness in the U.S., available to those who can help us take action to minimize its impact. External academics have proven this in peer-reviewed research.